Celltrion Pharm Inc (068760) — Financial Flexibility Index
Celltrion Pharm Inc (068760) has a Financial Flexibility Index of 0.08x as of September 2025. Free cash flow of ₩25.71 Billion (operating CF ₩23.44 Billion minus capex ₩2.27 Billion) represents 0% of total liabilities (₩319.38 Billion). Also explore 068760 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Celltrion Pharm Inc Financial Flexibility Index (2014–2024)
Historical Financial Flexibility Index trend for Celltrion Pharm Inc across 11 annual periods. Check asset allocation strategy of Celltrion Pharm Inc to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Celltrion Pharm Inc (2014–2024)
Year-by-year free cash flow to debt coverage for Celltrion Pharm Inc. For the full company profile including market capitalisation, see Celltrion Pharm Inc market capitalisation.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.23x | ₩62.57 Billion | ₩56.59 Billion | ₩272.54 Billion | ▲ +288.6% |
| 2023 | 0.06x | ₩15.65 Billion | ₩8.76 Billion | ₩264.98 Billion | ▲ +540.8% |
| 2022 | 0.01x | ₩2.24 Billion | ₩-4.05 Billion | ₩242.94 Billion | ▼ -97.3% |
| 2021 | 0.35x | ₩105.65 Billion | ₩93.15 Billion | ₩305.92 Billion | ▲ +9.3% |
| 2020 | 0.32x | ₩78.22 Billion | ₩36.25 Billion | ₩247.51 Billion | ▲ +3.4% |
| 2019 | 0.31x | ₩58.34 Billion | ₩27.85 Billion | ₩190.95 Billion | ▲ +159.0% |
| 2018 | 0.12x | ₩21.52 Billion | ₩14.31 Billion | ₩182.41 Billion | ▲ +329.4% |
| 2017 | -0.05x | ₩-9.08 Billion | ₩-10.16 Billion | ₩176.65 Billion | ▲ +34.7% |
| 2016 | -0.08x | ₩-13.02 Billion | ₩-15.21 Billion | ₩165.37 Billion | ▼ -130.6% |
| 2015 | 0.26x | ₩59.33 Billion | ₩13.36 Billion | ₩230.54 Billion | ▲ +16.4% |
| 2014 | 0.22x | ₩43.48 Billion | ₩17.33 Billion | ₩196.74 Billion | — |